Haberer Registered Investment Advisor’s AbbVie ABBV Stock Holding History

Haberer Registered Investment Advisor’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$18K	Sell	300 -4	-1%	-$242	0.01%	203
2014 Q4	$20K	Sell	304 -4,525	-94%	-$285K	0.01%	194
2014 Q3	$279K	Sell	4,829 -3,400	-41%	-$189K	0.13%	82
2014 Q2	$464K	Sell	8,229 -600	-7%	-$31.5K	0.21%	72
2014 Q1	$453K	Sell	8,829 -50	-0.6%	-$2.53K	0.22%	67
2013 Q4	$469K	Sell	8,879 -450	-5%	-$22.1K	0.2%	70
2013 Q3	$417K	Sell	9,329 -4,200	-31%	-$186K	0.15%	76
2013 Q2	$559K	Buy	+13,529	New	+$592K	0.15%	75

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Haberer Registered Investment Advisor's ABBV Position: Q1 2015 in Review

Haberer Registered Investment Advisor reduced its AbbVie (ABBV) stake by 1.3% in Q1 2015, selling an estimated $242 and leaving 300 shares worth $18K. The position accounts for 0.01% of the portfolio, ranked #203.

Haberer Registered Investment Advisor first reported a position in ABBV in Q2 2013 and has held it in 8 quarters since. The position peaked at $559K in Q2 2013. 1,600 funds tracked by Wall St. Rank hold ABBV as of Q1 2015.

Haberer Registered Investment Advisor held 300 shares of AbbVie worth $18K as of Q1 2015.
Haberer Registered Investment Advisor sold 4 AbbVie shares in Q1 2015, an estimated $242.
AbbVie made up 0.01% of Haberer Registered Investment Advisor's portfolio in Q1 2015, its #203 holding.
Haberer Registered Investment Advisor first reported a position in AbbVie in Q2 2013 and has held it in 8 quarters since.
Haberer Registered Investment Advisor's AbbVie position peaked at $559K in Q2 2013.
1,600 funds tracked by Wall St. Rank held AbbVie as of Q1 2015.

Based on Haberer Registered Investment Advisor's 13F filing for Q1 2015, filed 8 Apr 2015.